OA 17.06 Updated Analysis of KEYNOTE-024: Pembrolizumab vs Platinum-Based Chemotherapy for Advanced NSCLC With PD-L1 TPS ≥50%
2017
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
47
Citations
NaN
KQI